الاثنين، 21 نوفمبر 2016

ScienceDaily: Health & Medicine News

ScienceDaily: Health & Medicine News


Big data for chemistry: New method helps identify antibiotics in mass spectrometry datasets

Posted: 18 Nov 2016 11:50 AM PST

An international team of computer scientists has, for the first time, developed a method to find antibiotics hidden in huge but still unexplored mass spectrometry datasets.

Molecular 'pillars' team up to protect liver from toxic fat buildup

Posted: 18 Nov 2016 10:02 AM PST

A new study revealed a surprising relationship between two molecules – one that works to store fat and another that promotes fat burning for energy. The team found that the molecules complement each other to maintain a healthy level of fat in the liver.

Sleep apnea may make lung cancer more deadly

Posted: 17 Nov 2016 05:47 PM PST

New research shows that a lack of oxygen during sleep helps enable the spread of cancer cells.

Knowing your fitness number predicts your risk for future ill health

Posted: 17 Nov 2016 10:40 AM PST

Despite its high value in assessment of risk, fitness is not routinely measured in clinical practice. The likely reason for this is the costly and time consuming testing procedure that requires trained personnel and expensive equipment. Therefore, research has recently turned to non-exercise algorithms, which, without the need for expensive equipment or trained personnel, estimate fitness from available clinical information and information provided by the patient.

Pain sensors specialized for specific sensations

Posted: 17 Nov 2016 08:55 AM PST

Many pain-sensing nerves in the body are thought to respond to all types of 'painful events', but new research in mice reveals that in fact most are specialized to respond to specific types such as heat, cold or mechanical pain.

Drug combination therapy for estrogen-receptor–positive breast cancer passes critical step for worldwide approval

Posted: 17 Nov 2016 08:54 AM PST

A breakthrough drug palbociclib targets a key family of proteins to prevent cell growth in cancer, report investigators. The new study treated women with estrogen receptor positive (ER+), HER2-negative (HER2-) advanced breast cancer with a combination of palbociclib and standard anti-estrogen therapy letrozole. The study results found the drug combo increased progression-free survival from 14.5 months to over 25 months, compared to letrozole alone.

T cell channel could be targeted to treat head and neck cancers

Posted: 17 Nov 2016 08:54 AM PST

An ion channel, active within T cells (white blood cells), could be targeted to reduce the growth of head and neck cancers, researchers have discovered.

ليست هناك تعليقات:

إرسال تعليق